Amneal Pharmaceuticals, Inc. (AMRX) 은(는) 상장 기업입니다 헬스케어 섹터의 Drug Manufacturers - Specialty & Generic 산업에서 운영. 본사 소재지는 Bridgewater, NJ, 미국. 현재 CEO는 Chirag K. Patel.
AMRX 을(를) 보유 IPO 날짜 2018-05-07, 8,300 명의 정규직 직원, 에 상장 NASDAQ Global Select, 시가총액 $4.13B.
Amneal Pharmaceuticals, Inc. is a diversified pharmaceutical company that develops, manufactures, and distributes generic and specialty pharmaceutical products across multiple dosage forms and therapeutic areas. The company operates through three segments: Generics, which produces complex oral solids, injectables, ophthalmics, and other formulations; Specialty, which markets branded products for central nervous system disorders, endocrinology, and parasitic infections including brands like Rytary and Unithroid; and AvKARE, which supplies pharmaceuticals and medical products to government agencies and the Department of Defense. Amneal serves customers through wholesalers, distributors, hospitals, and retail pharmacies across the United States, India, Ireland, and internationally. Founded in 2002 and headquartered in Bridgewater, New Jersey, the company has established itself as a significant player in both the generic and specialty pharmaceutical markets.
